Patient Guide: 67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 8 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04023331
Status: TERMINATED
Condition: Neuroblastoma, Relapsed Neuroblastoma, Refractory Neuroblastoma
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 8 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Phoenix, Arizona
  • Saint Louis, Missouri
  • New York, New York
  • • And 5 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily